<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">bloodjour</journal-id><journal-title-group><journal-title xml:lang="ru">Гематология и трансфузиология</journal-title><trans-title-group xml:lang="en"><trans-title>Russian journal of hematology and transfusiology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">0234-5730</issn><issn pub-type="epub">2411-3042</issn><publisher><publisher-name>ООО Издательский дом «Практика»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.35754/0234-5730-2024-69-2-153-162</article-id><article-id custom-type="elpub" pub-id-type="custom">bloodjour-544</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Влияние частоты проведения донорского плазмафереза на ионный  и белковый состав крови донора</article-title><trans-title-group xml:lang="en"><trans-title>The influence of the frequency of donor plasmapheresis on the concentration of  ions and proteins in the blood of donors</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7660-8843</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ламзин</surname><given-names>И. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Lamzin</surname><given-names>I. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ламзин Иван Михайлович, кандидат медицинских наук, заведующий отделением заготовки крови и ее компонентов</p><p>432017, г. Ульяновск</p></bio><bio xml:lang="en"><p>Ivan M. Lamzin,  Cand. Sci. (Med.), Head of blood component producing department</p><p>432017, Ulyanovsk</p></bio><email xlink:type="simple">ivanlamzin@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0004-9419-2038</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Брыляева</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Brylyaeva</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Брыляева Елена Владимировна, кандидат медицинских наук, заведующая экспедицией с центром управления запасами компонентов донорской крови</p><p>432017, г. Ульяновск</p></bio><bio xml:lang="en"><p>Elena V. Brylyaeva,  Cand. Sci. (Med.), Head of blood component storing department</p><p>432017, Ulyanovsk</p></bio><email xlink:type="simple">brylyaeva@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6144-1019</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Хапман</surname><given-names>М. Э.</given-names></name><name name-style="western" xml:lang="en"><surname>Khapman</surname><given-names>M. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Хапман Марат Эрикович,  кандидат медицинских наук, главный врач</p><p>432017, г. Ульяновск</p></bio><bio xml:lang="en"><p>Marat E. Khapman, Cand. Sci. (Med.), Head</p><p>432017, Ulyanovsk</p></bio><email xlink:type="simple">hme19191@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6471-8922</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Горячая</surname><given-names>М. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Goryachaya</surname><given-names>M. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Горячая Марина Николаевна, заведующая клинико-диагностической лабораторией</p><p>432017, г. Ульяновск</p></bio><bio xml:lang="en"><p>Marina N. Goryachaya, Head of clinical diagnostic laboratory</p><p>432017, Ulyanovsk</p></bio><email xlink:type="simple">marina.gorya4aya@yandex.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">ГУЗ «Ульяновская областная станция переливания крови»<country>Россия</country></aff><aff xml:lang="en">Ulyanovsk Regional Blood Transfusion Station<country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru">ГУЗ «Ульяновский областной клинический госпиталь ветеранов войн»<country>Россия</country></aff><aff xml:lang="en">Ulyanovsk Regional War Veteran’s Hospital<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>17</day><month>08</month><year>2024</year></pub-date><volume>69</volume><issue>2</issue><fpage>153</fpage><lpage>162</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Ламзин И.М., Брыляева Е.В., Хапман М.Э., Горячая М.Н., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Ламзин И.М., Брыляева Е.В., Хапман М.Э., Горячая М.Н.</copyright-holder><copyright-holder xml:lang="en">Lamzin I.M., Brylyaeva E.V., Khapman M.E., Goryachaya M.N.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.htjournal.ru/jour/article/view/544">https://www.htjournal.ru/jour/article/view/544</self-uri><abstract><sec><title>Введение</title><p>Введение. Для многих центров службы крови плазмаферез  — стандартная процедура. Наиболее частыми осложнениями у  доноров плазмы являются вазовагальная и  цитратная реакции. Повторяющееся с  различной частотой в  течение длительного периода времени воздействие цитрата на  показатели крови доноров изучено недостаточно.</p></sec><sec><title>Цель</title><p>Цель: установить влияние частоты донорского плазмафереза на ионный и белковый состав крови донора.</p></sec><sec><title>Материалы и  методы</title><p>Материалы и  методы. Измерение концентрации общего белка в  сыворотке крови проводили биохимическим методом. Определение ионного состава сыворотки крови делали с использованием автоматического анализатора электролитов крови. Доноры плазмы были разделены на  группы в  зависимости от  пола и  частоты проведения плазмафереза (1–5; 6–10; 11–26 раз в год). Общее количество доноров, участвовавших в исследовании, составило 274 человека (155 мужчин и 119 женщин).</p></sec><sec><title>Результаты</title><p>Результаты. Выявлено достоверное снижение концентрации  связанного кальция в  группе доноров женского пола, сдававших плазму 11–26 раз по сравнению с группой доноров, сдававших плазму 1–5 раз в год. Выявлено достоверное снижение концентрации ионов железа в группе доноров женского пола, сдававших плазму 11–26 раз по сравнению с группой доноров, сдававших плазму 1–5 раз в год. Установлены достоверные отличия концентраций общего белка у доноров мужского пола между всеми тремя группами, у доноров женского пола между группами доноров, сдававших плазму 1–5 и 6–10 раз в год; 1–5 и 11–26 раз в год.</p></sec><sec><title>Заключение</title><p>Заключение.  Использование данных об изменениях показателей ионного и белкового обмена у доноров разного пола и  разной частоты донаций позволяет уменьшить риск развития цитратной реакции за  счет селективного подбора доноров плазмы.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Introduction</title><p>Introduction.  Plasmapheresis is a routine procedure in many blood  centers. The most common complications in plasma donors are vasovagal and citrate reactions. The effects of citrate exposure, repeated with different frequency over a long period  of time, have not been sufficiently studied.</p></sec><sec><title>Aim</title><p>Aim. to research the effect of the frequency of plasmapheresis on the concentration of ionic and protein composition in donor blood.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. The concentration of protein in blood serum was measured using a biochemical method. The concentration of ions was carried out using an automatic blood  electrolyte analyzer. Plasma donors were divided into groups depending on gender and frequency of plasmapheresis (1–5 times a year; 6–10 times a year; 11–26 times a year). The total number of donors involved in the study was 274 (155 men and 119 women).</p></sec><sec><title>Results</title><p>Results. A significant decrease in the concentration of bound calcium was revealed in the group of female donors who donated plasma 11–26 times compared to the group who donated plasma 1–5 times a year. A significant decrease in the concentration of iron ions was revealed in the group of female donors who donated plasma 11–26 times compared to the group who donated plasma 1–5 times a year. Statistically significant differences in the concentrations of total protein were revealed between all three groups of male donors, and between groups of female donors who donated plasma 1–5 times and 6–10 times a year; 1–5 times and 11–26 times a year.</p></sec><sec><title>Conclusion</title><p>Conclusion.  The use of data on changes in the parameters of ion and protein metabolism in donors of different sexes and different donation frequencies reduces the risk of developing a citrate reaction due to the selective selection of plasma donors.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>плазмаферез</kwd><kwd>цитратная реакция</kwd><kwd>доноры плазмы</kwd><kwd>ионы крови</kwd><kwd>белок крови</kwd></kwd-group><kwd-group xml:lang="en"><kwd>plasmapheresis</kwd><kwd>citrate reaction</kwd><kwd>plasma donors</kwd><kwd>blood ions</kwd><kwd>blood protein</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Приказ Министерства здравоохранения Российской Федерации от 28.10.2020 № 1166н «Об утверждении порядка прохождения донорами медицинского обследования и перечня медицинских противопоказаний (временных и постоянных) для сдачи крови и (или) ее компонентов и сроков отвода, которому подлежит лицо при наличии временных медицинских показаний, от донорства крови и (или) ее компонентов»</mixed-citation><mixed-citation xml:lang="en">The order of the Ministry of Health of the Russian Federation No. 1166n “On approval of the procedure for checking donors for medical indications and the list of physical conditions (temporary and permanent) for donating blood and (or) its components and withdrawal periods subject to the obligation of a person in the presence of temporary medical indications, from donation of blood and (or) its components”. (In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Crocco I., Franchini M., Garozzo G., et al. Adverse reactions in blood and apheresis donors: experience from two Italian transfusion centres. Blood Transfus. 2009; 7(1): 35вЂ“8. DOI: 10.2450/2008.0018-08.</mixed-citation><mixed-citation xml:lang="en">Crocco I., Franchini M., Garozzo G., et al. Adverse reactions in blood and apheresis donors: experience from two Italian transfusion centres. Blood Transfus. 2009; 7(1): 35–8. DOI: 10.2450/2008.0018-08.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Amrein K., Valentin A., Lanzer G., Drexler C. Adverse events and safety issues in blood donation--a comprehensive review. Blood Rev 2012; 26(1): 33вЂ“42. DOI: 10.1016/j.blre.2011.09.003.</mixed-citation><mixed-citation xml:lang="en">Amrein K., Valentin A., Lanzer G., Drexler C. Adverse events and safety issues in blood donation--a comprehensive review. Blood Rev 2012; 26(1): 33–42. DOI: 10.1016/j.blre.2011.09.003.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Teglkamp J., Handgaard L., Hansen T., et al. The donors perceived positive and negative effects of blood donation. Transfusion. 2020; 60(3): 553вЂ“60. DOI: 10.1111/trf.15717.</mixed-citation><mixed-citation xml:lang="en">Teglkamp J., Handgaard L., Hansen T., et al. The donors perceived positive and negative effects of blood donation. Transfusion. 2020; 60(3): 553–60. DOI: 10.1111/trf.15717.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Evers J., Taborski U. Distribution of citrate and citrate infusion rate during donor plasmaphereses. J Clin Apher. 2016; 31(1): 59вЂ“62. DOI: 10.1002/jca.21403.</mixed-citation><mixed-citation xml:lang="en">Evers J., Taborski U. Distribution of citrate and citrate infusion rate during donor plasmaphereses. J Clin Apher. 2016; 31(1): 59–62. DOI: 10.1002/jca.21403.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Lokhande T., Thomas S., Kumar G., Bajpai M. The Play of Citrate Infusion with Calcium in Plateletpheresis Donors. Indian J Hematol Blood Transfus. 2021 Apr; 37(2): 295вЂ“301. DOI: 10.1007/s12288-020-01339-z.</mixed-citation><mixed-citation xml:lang="en">Lokhande T., Thomas S., Kumar G., Bajpai M. The Play of Citrate Infusion with Calcium in Plateletpheresis Donors. Indian J Hematol Blood Transfus. 2021 Apr; 37(2): 295–301. DOI: 10.1007/s12288-020-01339-z.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Liu B., Dong D., Wang Z., et al. Analysis of influencing factors of serum total protein and serum calcium content in plasma donors. Peer J. 2022; 10: e14474. DOI: 10.7717/peerj.14474.</mixed-citation><mixed-citation xml:lang="en">Liu B., Dong D., Wang Z., et al. Analysis of influencing factors of serum total protein and serum calcium content in plasma donors. Peer J. 2022; 10: e14474. DOI: 10.7717/peerj.14474.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Das S.S., Chaudhary R., Khetan D., et al. Calcium and magnesium levels during automated plateletpheresis in normal donors. Transfus Med. 2005; 15(3): 233вЂ“6. DOI: 10.1111/j.1365-3148.2005.00576.x.</mixed-citation><mixed-citation xml:lang="en">Das S.S., Chaudhary R., Khetan D., et al. Calcium and magnesium levels during automated plateletpheresis in normal donors. Transfus Med. 2005; 15(3): 233–6. DOI: 10.1111/j.1365-3148.2005.00576.x.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Amrein K., Katschnig C., Sipurzynski S., et al. Apheresis affects bone and mineral metabolism. Bone. 2010; 46(3): 789вЂ“95. DOI: 10.1016/j.bone.2009.11.008.</mixed-citation><mixed-citation xml:lang="en">Amrein K., Katschnig C., Sipurzynski S., et al. Apheresis affects bone and mineral metabolism. Bone. 2010; 46(3): 789–95. DOI: 10.1016/j.bone.2009.11.008.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Toffaletti J., Nissenson R., Endres D., et al. Influence of continuous infusion of citrate on responses of immunoreactive parathyroid hormone, calcium and magnesium components, and other electrolytes in normal adults during plateletapheresis. 1985; 60(5): 874вЂ“9. DOI: 10.1210/jcem-60-5-874.</mixed-citation><mixed-citation xml:lang="en">Toffaletti J., Nissenson R., Endres D., et al. Influence of continuous infusion of citrate on responses of immunoreactive parathyroid hormone, calcium and magnesium components, and other electrolytes in normal adults during plateletapheresis. 1985; 60(5): 874–9. DOI: 10.1210/jcem-60-5-874.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Bolan CD, Cecco SA, Yau YY, et al. Randomized placebo-controlled study of oral calcium carbonate supplementation in plateletpheresis: II. Metabolic effects. Transfusion. 20 03;43(10):1414-1422. doi:10.1046/j.1537-2995.2003.00513.x</mixed-citation><mixed-citation xml:lang="en">Bolan CD, Cecco SA, Yau YY, et al. Randomized placebo-controlled study of oral calcium carbonate supplementation in plateletpheresis: II. Metabolic effects. Transfusion. 20 03;43(10):1414-1422. doi:10.1046/j.1537-2995.2003.00513.x</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Mane V.B., Jagtap P.E., Nagane N.S., et al. The significance of evolution of haematocrit in plateletpheresis donors. J Clin Diagn Res. 2015; 9(4): BC06вЂ“7. DOI: 10.7860/JCDR/2015/8292.5746.</mixed-citation><mixed-citation xml:lang="en">Mane V.B., Jagtap P.E., Nagane N.S., et al. The significance of evolution of haematocrit in plateletpheresis donors. J Clin Diagn Res. 2015; 9(4): BC06–7. DOI: 10.7860/JCDR/2015/8292.5746.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Haynes S., Hickson E., Linden J., et al. Dietary citrate and plasma ionized calcium: Implications for platelet donors. J Clin Apher. 2018; 33(3): 222вЂ“5. DOI: 10.1002/jca.21575.103147.</mixed-citation><mixed-citation xml:lang="en">Haynes S., Hickson E., Linden J., et al. Dietary citrate and plasma ionized calcium: Implications for platelet donors. J Clin Apher. 2018; 33(3): 222–5. DOI: 10.1002/jca.21575.103147.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Pandey P.K., Tiwari A., Agarwal N., et al. Prophylactic administration of oral calcium carbonate during plateletpheresis: A bicentric prospective study. Asian J Transfus Sci. 2020; 14(1): 19вЂ“22. DOI: 10.4103/ajts.AJTS_114_17.</mixed-citation><mixed-citation xml:lang="en">Pandey P.K., Tiwari A., Agarwal N., et al. Prophylactic administration of oral calcium carbonate during plateletpheresis: A bicentric prospective study. Asian J Transfus Sci. 2020; 14(1): 19–22. DOI: 10.4103/ajts.AJTS_114_17.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Weinstein R., Haynes S., Zhao Y., et al. A liquid calcium+vitamin D 3 supplement is effective prophylaxis against hypocalcemic toxicity during apheresis platelet donation. J Clin Apher. 2018; 33(1): 60вЂ“4. DOI: 10.1002/jca.21565.</mixed-citation><mixed-citation xml:lang="en">Weinstein R., Haynes S., Zhao Y., et al. A liquid calcium+vitamin D 3 supplement is effective prophylaxis against hypocalcemic toxicity during apheresis platelet donation. J Clin Apher. 2018; 33(1): 60–4. DOI: 10.1002/jca.21565.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Fujii K., Fujii N., Kondo T., et al. Effectiveness of supplemental oral calcium drink in preventing citrate-related adverse effects in peripheral blood progenitor cell collection. Transfus Apheres Sci. 2021; 60(4): 103147. DOI: 10.1016/j.transci.</mixed-citation><mixed-citation xml:lang="en">Fujii K., Fujii N., Kondo T., et al. Effectiveness of supplemental oral calcium drink in preventing citrate-related adverse effects in peripheral blood progenitor cell collection. Transfus Apheres Sci. 2021; 60(4): 103147. DOI: 10.1016/j.transci.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Кашин К.П., Ковтунова М.Е., Кунов В.К. Влияние количества донаций на показатели белкового обмена у доноров плазмы для фракционирования. Вестник службы крови России. 2013; 3: 24–6.</mixed-citation><mixed-citation xml:lang="en">Kashin K.P., Kovtunova M.E., Kunov V.K. The influence of the number of donations on the indicators of protein metabo lism in plasma donors for fractionation. Vestnik Slugby krovi Rossii. 2013; 3: 24–6. (In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Toffaletti J. Changes in protein-bound, complex-bound, and ionized calcium related to parathyroid hormone levels in healthy donors during plateletapheresis. Transfusion. 1983; 23(6): 471вЂ“5. DOI: 10.1046/j.1537-2995.1983.23684074265.x.</mixed-citation><mixed-citation xml:lang="en">Toffaletti J. Changes in protein-bound, complex-bound, and ionized calcium related to parathyroid hormone levels in healthy donors during plateletapheresis. Transfusion. 1983; 23(6): 471–5. DOI: 10.1046/j.1537-2995.1983.23684074265.x.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Monchi M. Citrate pathophysiology and metabolism. Transfus Apher Sci 2017; 56(1): 28вЂ“30. DOI: 10.1016/j.transci.2016.12.013.</mixed-citation><mixed-citation xml:lang="en">Monchi M. Citrate pathophysiology and metabolism. Transfus Apher Sci 2017; 56(1): 28–30. DOI: 10.1016/j.transci.2016.12.013.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Chonchol M., Smogorzewski M., Stubbs J., et al. Disorders of calcium, magnesium, and phosphate balance. In Brenner and RectorвЂ™s The Kidney, Eleventh Edition Philadelphia, PA: Elsevier Inc; 2019: 580вЂ“613.</mixed-citation><mixed-citation xml:lang="en">Chonchol M., Smogorzewski M., Stubbs J., et al. Disorders of calcium, magnesium, and phosphate balance. In Brenner and Rector’s The Kidney, Eleventh Edition Philadelphia, PA: Elsevier Inc; 2019: 580–613.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Tinawi M. Disorders of Calcium Metabolism: Hypocalcemia and Hypercalcemia. Cureus. 2021; 13(1): e12420. DOI: 10.7759/cureus.12420.</mixed-citation><mixed-citation xml:lang="en">Tinawi M. Disorders of Calcium Metabolism: Hypocalcemia and Hypercalcemia. Cureus. 2021; 13(1): e12420. DOI: 10.7759/cureus.12420.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
